Literature DB >> 23160006

Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients.

Lori S Muffly1, Melissa Boulukos, Kate Swanson, Masha Kocherginsky, Paula Del Cerro, Linda Schroeder, Lisa Pape, Martine Extermann, Koen Van Besien, Andrew S Artz.   

Abstract

Comprehensive geriatric assessment (CGA) is frequently used in oncology to measure the health status of older adults with cancer, but it has not been studied in allogeneic hematopoietic cell transplantation (HCT). We conducted a prospective pilot study of CGA in allogeneic HCT recipients aged ≥50 years to examine the prevalence of vulnerabilities in this population. Patients aged ≥50 years eligible for HCT were enrolled. CGA consisted mainly of self-reported, performance-based, and chart-extracted measures evaluating domains of comorbidity, physical and mental function, frailty, disability, and nutrition. Of 238 eligible patients, 166 completed CGA and underwent HCT. Only 1% had a Zubrod Performance Status score >1; 44% had high comorbidity defined by the Hematopoietic Cell Transplantation Comorbidity Index, and 66% had high comorbidity defined by the Cumulative Illness Rating Scale-Geriatrics. The presence of additional vulnerability was frequent. Disability was present in 40% by Instrumental Activities of Daily Living. Self-reported physical and mental function were significantly lower than population age group norms, 58% were pre-frail, and 25% were frail. Among those with Zubrod Performance Status score of 0, 28% demonstrated disability, 58% were pre-frail, 15% were frail, 35% reported low physical function, and 55% reported low mental function. CGA uncovers a substantial prevalence of undocumented impairments in functional status, frailty, disability, and mental health in older allogeneic HCT recipients.
Copyright © 2013 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23160006     DOI: 10.1016/j.bbmt.2012.11.006

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  42 in total

Review 1.  Frailty in Hematologic Malignancy.

Authors:  Thuy T Koll; Ashley E Rosko
Journal:  Curr Hematol Malig Rep       Date:  2018-06       Impact factor: 3.952

Review 2.  Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).

Authors:  Ehab Atallah; Kathryn Bylow; Jesse Troy; Wael Saber
Journal:  Curr Hematol Malig Rep       Date:  2014-03       Impact factor: 3.952

3.  Comprehensive geriatric assessment in the older cancer patient: coming of age in clinical cancer care.

Authors:  Cynthia Owusu; Nathan A Berger
Journal:  Clin Pract (Lond)       Date:  2014

Review 4.  Patient selection for allogeneic hematopoietic cell transplantation (HCT): the evolution of HCT risk assessment.

Authors:  Lori Muffly
Journal:  Curr Hematol Malig Rep       Date:  2015-03       Impact factor: 3.952

Review 5.  Biologic vs physiologic age in the transplant candidate.

Authors:  Andrew S Artz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 6.  The who, how and why: Allogeneic transplant for acute myeloid leukemia in patients older than 60years.

Authors:  Sarah A Wall; Steven Devine; Sumithira Vasu
Journal:  Blood Rev       Date:  2017-07-15       Impact factor: 8.250

7.  The EBMT/EMCL consensus project on the role of autologous and allogeneic stem cell transplantation in mantle cell lymphoma.

Authors:  S Robinson; P Dreger; D Caballero; P Corradini; C Geisler; M Ghielmini; S Le Gouill; E Kimby; S Rule; U Vitolo; M Dreyling; O Hermine
Journal:  Leukemia       Date:  2014-07-18       Impact factor: 11.528

8.  Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic.

Authors:  Tanya M Wildes; Derek L Stirewalt; Bruno Medeiros; Arti Hurria
Journal:  J Natl Compr Canc Netw       Date:  2014-01       Impact factor: 11.908

9.  Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients.

Authors:  Lori S Muffly; Masha Kocherginsky; Wendy Stock; Quynh Chu; Michael R Bishop; Lucy A Godley; Justin Kline; Hongtao Liu; Olatoyosi M Odenike; Richard A Larson; Koen van Besien; Andrew S Artz
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

10.  Hematopoietic cell transplantation in older adults: deciding or decision-making?

Authors:  A S Artz; S Chow
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.